A23V2250/5024

Encapsulation system for protection of probiotics during processing

Comestible products, for example beverage products, are disclosed containing encapsulated probiotic bacteria having resistance to subjection to at least thermal and acidic conditions. Beverage products include at least one aqueous liquid and capsules comprising a gelled mixture of alginate and denatured protein, and probiotic bacteria entrapped within the gelled mixture. The average particle size of the capsules is optionally less than 1000 microns (m) in diameter, such as less than 500 m in diameter. Methods are provided for making such encapsulated probiotics by providing a mixture comprising sodium alginate, denatured protein and active probiotic cells, and combining the mixture with a divalent cation to initiate cold gelation of the sodium alginate and denatured protein to form a second mixture. The second mixture is passed through an opening having a diameter of less than 1000 m to form capsules. The weight ratio of protein to alginate is from 1:1 to 9:1.

Encapsulation system for protection of probiotics during processing

Comestible products, for example beverage products, are disclosed containing encapsulated probiotic bacteria having resistance to subjection to at least thermal and acidic conditions. Beverage products include at least one aqueous liquid and capsules comprising a gelled mixture of alginate and denatured protein, and probiotic bacteria entrapped within the gelled mixture. The average particle size of the capsules is optionally less than 1000 microns (m) in diameter, such as less than 500 m in diameter. Methods are provided for making such encapsulated probiotics by providing a mixture comprising sodium alginate, denatured protein and active probiotic cells, and combining the mixture with a divalent cation to initiate cold gelation of the sodium alginate and denatured protein to form a second mixture. The second mixture is passed through an opening having a diameter of less than 1000 m to form capsules. The weight ratio of protein to alginate is from 1:1 to 9:1.

Composition comprising neoagarooligosaccharide as active ingredient, for prevention or treatment of sepsis or septic shock

The present invention relates to a composition for prevention or treatment of sepsis or septic shock, in which the composition includes neoagarooligosaccharide as an active ingredient, and the neoagarooligosaccharide according to the present invention has an excellent effect in terms of immune enhancement by effectively suppressing inflammation, and also exhibits a good effect in preventing sepsis, and therefore can be effectively used in pharmaceuticals and functional foods for prevention or treatment of sepsis or septic shock and immune enhancement.

Composition comprising neoagarooligosaccharide as active ingredient, for prevention or treatment of sepsis or septic shock

The present invention relates to a composition for prevention or treatment of sepsis or septic shock, in which the composition includes neoagarooligosaccharide as an active ingredient, and the neoagarooligosaccharide according to the present invention has an excellent effect in terms of immune enhancement by effectively suppressing inflammation, and also exhibits a good effect in preventing sepsis, and therefore can be effectively used in pharmaceuticals and functional foods for prevention or treatment of sepsis or septic shock and immune enhancement.

COMPOSITION COMPRISING NEOAGAROOLIGOSACCHARIDE AS ACTIVE INGREDIENT, FOR PREVENTION OR TREATMENT OF SEPSIS OR SEPTIC SHOCK
20190290678 · 2019-09-26 ·

The present invention relates to a composition for prevention or treatment of sepsis or septic shock, in which the composition includes neoagarooligosaccharide as an active ingredient, and the neoagarooligosaccharide according to the present invention has an excellent effect in terms of immune enhancement by effectively suppressing inflammation, and also exhibits a good effect in preventing sepsis, and therefore can be effectively used in pharmaceuticals and functional foods for prevention or treatment of sepsis or septic shock and immune enhancement.

COMPOSITION COMPRISING NEOAGAROOLIGOSACCHARIDE AS ACTIVE INGREDIENT, FOR PREVENTION OR TREATMENT OF SEPSIS OR SEPTIC SHOCK
20190290678 · 2019-09-26 ·

The present invention relates to a composition for prevention or treatment of sepsis or septic shock, in which the composition includes neoagarooligosaccharide as an active ingredient, and the neoagarooligosaccharide according to the present invention has an excellent effect in terms of immune enhancement by effectively suppressing inflammation, and also exhibits a good effect in preventing sepsis, and therefore can be effectively used in pharmaceuticals and functional foods for prevention or treatment of sepsis or septic shock and immune enhancement.

PROTEIN GUMMY COMPOSITIONS
20190289872 · 2019-09-26 ·

A protein gummy composition comprises between 40% and 80% by weight of a sweetener, between 5% and 30% by weight of a plant-based protein, and between 1% and 10% by weight of a plant-based gelling agent. The sweetener may be at least one sweetener selected from the group of sweeteners including isomalto-oligosaccharide, maltitol, inulin, tapioca syrup, and corn syrup. The plant-based protein may be at least one plant-based protein selected from the group of plant-based proteins including pea protein, rice protein, sunflower protein, hemp protein, and chia protein. The plant-based gelling agent may be at least one plant-based gelling agent selected from the group of plant-based gelling agents including agar, pectin, carrageenan, and locust bean gum.

PROTEIN GUMMY COMPOSITIONS
20190289872 · 2019-09-26 ·

A protein gummy composition comprises between 40% and 80% by weight of a sweetener, between 5% and 30% by weight of a plant-based protein, and between 1% and 10% by weight of a plant-based gelling agent. The sweetener may be at least one sweetener selected from the group of sweeteners including isomalto-oligosaccharide, maltitol, inulin, tapioca syrup, and corn syrup. The plant-based protein may be at least one plant-based protein selected from the group of plant-based proteins including pea protein, rice protein, sunflower protein, hemp protein, and chia protein. The plant-based gelling agent may be at least one plant-based gelling agent selected from the group of plant-based gelling agents including agar, pectin, carrageenan, and locust bean gum.

FOODSTUFF

A foodstuff comprises filamentous fungus, which is preferably a Fusarium specie, and agar. The foodstuff is preferably a packaged sliced product which also includes one or more flavourants. The foodstuff is preferably suitable for vegans.

FOODSTUFF

A foodstuff comprises filamentous fungus, which is preferably a Fusarium specie, and agar. The foodstuff is preferably a packaged sliced product which also includes one or more flavourants. The foodstuff is preferably suitable for vegans.